NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients
Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients

NCT02664623

CompletedNA

Sponsor: Centre Hospitalier Universitaire de Nīmes

Conditions: Multiple Sclerosis

Interventions: Individual dietary consultations, Dietary advice sheet

Countries: France

The main objective of this study is to measure effectiveness at 6 months of personalized dietary advice versus dietary counseling via delivery of a standard advice sheet for optimizing dietary calcium intake (assessed by a food survey based on CIQUAL\* data) in MS patients with ambulatory monitoring. \*CIQUAL Data: Table of nutritional food composition available on the ANSES (National Agency for Sanitary Security of Food, Environment and Labour) website, published by the Observatory of the Nutritional Quality of Foods. This table includes 1,500 sheets of 58 nutritional components. The data is integrated into the software for calculating ingesta (DATAMEAL) at the Nîmes University Hospital.

Eligibility overview

Sex: ALL

Age: 18 Years to 69 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* Patient with a confirmed diagnosis of remitting multiple sclerosis
* Ambulatory patient (EDSS score \< 6.5) who has never had a dietary consultation concerning the optimization of calcium intake

Exclusion Criteria:

* The patient is participating in another non-observational study
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* The subject is not able to complete a self-administered questionnaire
* Vitamin D deficiency linked to currently active digestive or general diseases
* Moderate or severe renal impairment (creatinine clearance \<60ml / min)
* Situations accompanied by increased vulnerability to hypercalcemia, eg arrhythmia or known heart disease, treatment with digitalis, subjects with nephrolithiasis
Locations (2)
  • Alès, France
  • Nîmes, France